| HUTCHMED (CHINA) LS-,1 |
| China |
| Gesundheit |
| KYG4672N1198 / A2PJ5B |
| H7T2 (Frankfurt) |
| FRA:H7T2, ETR:H7T2, H7T2:GR |
| - |
| https://www.hutch-med.com.. |
|
HUTCHMED (China) Limited is an innovative, commercial-stage biopharmaceutical company headquartered in Hong Kong, focused on the discovery, global development, and commercialization of targeted therapies and immunotherapies for cancer and immunologic..
>Volltext.. |
| 2244.92 Mio. EUR |
| 1188.12 Mio. EUR |
| 470.42 Mio. EUR |
| -22.18 Mio. EUR |
| 391.7 Mio. EUR |
| 0.46 EUR |
| 83.82 Mio. EUR |
| 61.08 Mio. EUR |
| -55.48 Mio. EUR |
| 4.33 |
| -23.48% |
| 963.36% |
| - |
| - |
| - |
| - |
| HUTCHMED |
| 08.04.26 |
|